| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2885581 | Annals of Vascular Surgery | 2016 | 7 Pages |
Abstract
These initial results suggest that hybrid operation with supra-aortic debranching, and TEVAR is an acceptable treatment option for patients with complex aortic arch disease. Short-term and midterm outcomes are acceptable. Further research with large sample size and long-term follow-up is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xingwei He, Wanjun Liu, Zhuxi Li, Xintian Liu, Tao Wang, Cheng Ding, Hesong Zeng,